Navigation Links
UCLA performs first 'breathing lung' transplant in United States
Date:11/26/2012

First there was the "heart in a box," a revolutionary experimental technology that allows donor hearts to be delivered to transplant recipients warm and beating rather than frozen in an ice cooler.

Now that same technology is being used to deliver "breathing lungs."

The lung transplant team at Ronald Reagan UCLA Medical successfully performed the nation's first "breathing lung" transplant in mid-November. The patient, a 57-year-old who suffered from pulmonary fibrosis a disease in which the air sacs of the lungs are gradually replaced by scar tissue received two new lungs and is recuperating from the seven-hour surgery.

The groundbreaking transplant involved an experimental organ-preservation device known as the Organ Care System (OCS), which keeps donor lungs functioning and "breathing" in a near-physiologic state outside the body during transport. The current standard involves transporting donor lungs in a non-functioning, non-breathing state inside an icebox.

With the OCS, the lungs are removed from a donor's body and are placed in a high-tech OCS box, where they are immediately revived to a warm, breathing state and perfused with oxygen and a special solution supplemented with packed red-blood cells. The device also features monitors that display how the lungs are functioning during transport.

"Organs were never meant to be frozen on ice," said Dr. Abbas Ardehali, a professor of cardiothoracic surgery and director of the heart and lung transplantation program at Ronald Reagan UCLA Medical Center. "Lungs are very sensitive and can easily be damaged during the donation process. The cold storage method does not allow for reconditioning of the lungs before transplantation, but this promising 'breathing lung' technology enables us to potentially improve the function of the donor lungs before they are placed in the recipient."

UCLA is currently leading the U.S. arm of the international, multicenter phase 2 clinical INSPIRE study of the OCS, developed by medical device company TransMedics; Ardehali is the principal investigator for UCLA. The purpose of the trial is to compare donor lungs transported using the OCS technology with the standard icebox method. The INSPIRE trial is also underway at lung transplant centers in Europe, Australia and Canada and will enroll a total of 264 randomized patients.

According to Ardehali, in addition to potentially improving donor-lung function, the technology could help transplant teams better assess donor lungs, since the organs can be tested in the device, over a longer period of time.

In addition, it could help expand the donor pool by allowing donor lungs to be safely transported across longer distances.

"For patients with end-stage lung disease, lung transplantation can dramatically improve the patient's symptoms and offer relief from severe shortness of breath," said Dr. David Ross, professor of medicine and medical director of UCLA's lung and heart-lung transplantation program and UCLA's pulmonary arterial hypertension and thromboendarterectomy program. "The 'breathing lung' technology could potentially make the transplantation process even better and improve the outcomes for patients suffering from lung disease."

The "breathing lung" device follows on the heels of TransMedics' "heart in a box" technology, which delivers donor hearts in a similar manner. The multi-center national study of the heart technology, also led by UCLA, is ongoing.

Results of a preliminary OCS lung study conducted in Europe were published in the Oct. 10 edition of the journal Lancet. The findings showed good lung transplantation outcomes following preservation using the OCS system. Read the Lancet study.


'/>"/>

Contact: Amy Albin
aalbin@mednet.ucla.edu
31-007-948-672
University of California - Los Angeles Health Sciences
Source:Eurekalert  

Related medicine news :

1. Metformin Outperforms Common Class of Diabetes Drugs in Study
2. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
3. US performs worst on potentially preventable death rates compared to France, Germany, and the UK
4. First targeted nanomedicine to enter human clinical studies
5. First contact: Early intervention key in diagnosis and treatment of serious mental illness
6. Donor Kidney Re-Used in Second Patient After Failing in First
7. Many Who First Misuse Prescription Pills Get Them From Friends, Family: Report
8. First-of-its-kind Menopause Map helps women navigate treatment
9. First recipients of AcademyHealths Presidential Scholarship announced
10. Kessler Foundation researchers present at first International Congress on Cognition in MS
11. Whos the Dad? First-Trimester Blood Test May Tell
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCLA performs first 'breathing lung' transplant in United States
(Date:1/23/2017)... ... January 23, 2017 , ... ... series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 ... which was founded in 2008 to address the limitations of fatigue monitoring technologies ...
(Date:1/23/2017)... ... , ... Sharon Kleyne, America’s leading water researcher, advocate and feared enemy of ... making new water infrastructure a number one priority. “As we usher in a new ... to become a top priority of our new political change agents.” Kleyne pointed out ...
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture measurement ... the right method is paramount to success. Selecting an inappropriate measurement method can ... multiple persons use the same equipment. Rare or expensive substances are wasted and ...
(Date:1/23/2017)... ROSEMONT, IL (PRWEB) , ... ... ... Research and Education Foundation (OREF), in partnership with the American Society of ... Patient Safety Foundation (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and ...
(Date:1/23/2017)... (PRWEB) , ... January 23, ... ... Partnership (SNP) has launched online education programs and resources at seafoodnutrition.org/programs and ... nutritional benefits of a seafood-rich diet. These resources have been developed for ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , January 23, 2017 Ahead of ... to see how they have fared at the close: Kite Pharma ... Inc. (NASDAQ: OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... Biotechnology shares were relative laggards on Friday, January 20 th , ... our complimentary research reports on these stocks now at: ...
(Date:1/23/2017)... 2017  ResMed (NYSE : RMD), BMC (Pékin, Chine) et ... aujourd,hui qu,ils se sont mis d,accord sur le règlement ... BMC et 3B seront autorisés à vendre leurs produits ... et ResMed effectuera le paiement de la décision en ... de Floride entre les deux parties. Le règlement n,inclut ...
(Date:1/23/2017)... Jan. 23, 2017 Just two weeks remain until legal experts ... gather in Central London to discuss the flow ... in the market, Parallel Trade 2017 . In the ... of attendees which is available to read in the event download ... Some of ...
Breaking Medicine Technology: